PTIX logo

Protagenic Therapeutics (PTIX) Return On Equity

Annual ROE

-136.32%
-84.92%-165.21%

December 31, 2023


Summary


Performance

PTIX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTIXprofitabilitymetrics:

Quarterly ROE

-308.96%
-70.59%-29.61%

September 30, 2024


Summary


Performance

PTIX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPTIXprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

PTIX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-165.2%-29.6%
3 y3 years-161.5%-29.6%
5 y5 years-111.2%-29.6%

PTIX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-199.7%at low-668.6%at low
5 y5-year-149.4%at low-176.7%at low
alltimeall time-102.7%+57.9%-106.0%+90.6%

Protagenic Therapeutics ROE History

DateAnnualQuarterly
Sep 2024
-
-308.96%(+29.6%)
Jun 2024
-
-238.37%(+52.4%)
Mar 2024
-
-156.36%(+53.6%)
Dec 2023
-136.32%(+165.2%)
-101.80%(+48.4%)
Sep 2023
-
-68.58%(+29.7%)
Jun 2023
-
-52.89%(+31.6%)
Mar 2023
-
-40.20%(-11.6%)
Dec 2022
-51.40%(+13.0%)
-45.47%(+1.4%)
Sep 2022
-
-44.83%(+10.1%)
Jun 2022
-
-40.73%(-13.3%)
Mar 2022
-
-46.99%(-24.3%)
Dec 2021
-45.49%(-120.5%)
-62.11%(-32.6%)
Sep 2021
-
-92.18%(-64.6%)
Jun 2021
-
-260.29%(-195.3%)
Mar 2021
-
273.01%(-9.3%)
Dec 2020
221.68%(-19.7%)
301.03%(-21.5%)
Sep 2020
-
383.25%(+15.1%)
Jun 2020
-
332.90%(-1.0%)
Mar 2020
-
336.20%(-16.5%)
Dec 2019
275.99%(-77.2%)
402.64%(-26.0%)
Sep 2019
-
544.33%(-60.4%)
Jun 2019
-
1376.29%(-141.7%)
Mar 2019
-
-3298.26%(+427.9%)
Dec 2018
1212.66%(-754.4%)
-624.79%(+94.5%)
Sep 2018
-
-321.24%(+46.9%)
Jun 2018
-
-218.69%(+42.7%)
Mar 2018
-
-153.21%(+17.9%)
Dec 2017
-185.32%(+101.7%)
-129.95%(+25.9%)
Sep 2017
-
-103.23%(+15.2%)
Jun 2017
-
-89.58%(+10.0%)
Mar 2017
-
-81.42%(+3.9%)
Dec 2016
-91.87%(-195.9%)
-78.35%(-12.8%)
Sep 2016
-
-89.90%(-30.7%)
Jun 2016
-
-129.74%(-68.6%)
Mar 2016
-
-412.85%(-555.7%)
Dec 2015
-
90.59%(-18.7%)
Sep 2015
-
111.49%(-25.0%)
Jun 2015
95.77%(-98.1%)
148.63%(-35.0%)
Mar 2015
-
228.57%(-55.0%)
Dec 2014
-
507.86%(-51.0%)
Sep 2014
-
1036.36%(-79.8%)
Jun 2014
5138.10%(>+9900.0%)
5142.86%(-1066.7%)
Jun 2013
5.96%(-105.1%)
-
Sep 2011
-
-532.01%(+121.7%)
Jun 2011
-
-239.98%(+65.1%)
Mar 2011
-
-145.36%(+30.5%)
Dec 2010
-117.71%
-111.40%(-18.4%)
Sep 2010
-
-136.47%(+32.8%)
DateAnnualQuarterly
Jun 2010
-
-102.77%(+30.5%)
Mar 2010
-
-78.78%(+24.9%)
Dec 2009
-73.68%(-77.2%)
-63.06%(-61.5%)
Sep 2009
-
-163.70%(+33.8%)
Jun 2009
-
-122.35%(+26.5%)
Mar 2009
-
-96.72%(-5.2%)
Dec 2008
-323.76%(+605.7%)
-102.01%(>+9900.0%)
Sep 2008
-
-0.14%(-94.9%)
Jun 2008
-
-2.72%(-68.0%)
Mar 2008
-
-8.50%(-70.2%)
Dec 2007
-45.88%(-135.6%)
-28.57%(-2.2%)
Sep 2007
-
-29.20%(-9.8%)
Jun 2007
-
-32.39%(-39.6%)
Mar 2007
-
-53.62%(-104.2%)
Dec 2006
128.83%(+184.1%)
-
Oct 2006
-
1269.57%(-1419.0%)
Jul 2006
-
-96.25%(+376.0%)
Jul 2006
45.35%(-734.3%)
-
Apr 2006
-
-20.22%(+60.9%)
Jan 2006
-
-12.57%(-11.0%)
Oct 2005
-
-14.13%(-1.2%)
Jul 2005
-7.15%(-75.0%)
-
Jul 2004
-28.62%(+419.4%)
-
Apr 2003
-
-14.30%(+12.0%)
Jan 2003
-
-12.77%(+24.2%)
Oct 2002
-
-10.28%(+89.3%)
Jul 2002
-5.51%(-615.0%)
-5.43%(+24.3%)
Apr 2002
-
-4.37%(+49.1%)
Jan 2002
-
-2.93%(+985.2%)
Oct 2001
-
-0.27%(-125.7%)
Jul 2001
1.07%(-87.4%)
1.05%(-80.7%)
Apr 2001
-
5.45%(-21.5%)
Jan 2001
-
6.94%(-9.2%)
Oct 2000
-
7.64%(-14.9%)
Jul 2000
8.50%(-271.7%)
8.98%(+3107.1%)
Apr 2000
-
0.28%(-110.3%)
Jan 2000
-
-2.73%(-34.1%)
Oct 1999
-
-4.14%(-25.1%)
Jul 1999
-4.95%(-204.0%)
-5.53%(-626.7%)
Apr 1999
-
1.05%(-77.1%)
Jan 1999
-
4.59%(-1.3%)
Oct 1998
-
4.65%(-1.5%)
Jul 1998
4.76%(-170.3%)
4.72%(+60.0%)
Apr 1998
-
2.95%(+298.6%)
Jan 1998
-
0.74%(-119.9%)
Oct 1997
-
-3.71%(-44.5%)
Jul 1997
-6.77%
-6.68%(+29.2%)
Apr 1997
-
-5.17%(+0.4%)
Jan 1997
-
-5.15%

FAQ

  • What is Protagenic Therapeutics annual return on equity?
  • What is the all time high annual ROE for Protagenic Therapeutics?
  • What is Protagenic Therapeutics annual ROE year-on-year change?
  • What is Protagenic Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Protagenic Therapeutics?
  • What is Protagenic Therapeutics quarterly ROE year-on-year change?

What is Protagenic Therapeutics annual return on equity?

The current annual ROE of PTIX is -136.32%

What is the all time high annual ROE for Protagenic Therapeutics?

Protagenic Therapeutics all-time high annual return on equity is 5138.10%

What is Protagenic Therapeutics annual ROE year-on-year change?

Over the past year, PTIX annual return on equity has changed by -84.92% (-165.21%)

What is Protagenic Therapeutics quarterly return on equity?

The current quarterly ROE of PTIX is -308.96%

What is the all time high quarterly ROE for Protagenic Therapeutics?

Protagenic Therapeutics all-time high quarterly return on equity is 5142.86%

What is Protagenic Therapeutics quarterly ROE year-on-year change?

Over the past year, PTIX quarterly return on equity has changed by -70.59% (-29.61%)